|

Psychedelic Decriminalization Update : Colorado, Oklahoma & Maine Move To Legalize Psychedelics?



Psychedelic Decriminalization Update

Today, we take a look at 3 states who are moving to decriminalize, or even legalize, certain psychedelic compounds. We also look at some backward thinking moves by the DEA, and a Canadian Decriminalization bill.

Form to contact the DEA: https://www.federalregister.gov/documents/2022/01/14/2022-00713/schedules-of-controlled-substances-placement-of-4-hydroxy-nn

Follow us on Twitter:
@PsycSpotlight
@Psy_Invest
@psy_holy

Follow us on Instagram:
@psycspotlight
@thepsychedelicinvestor

To learn more about the emerging psychedelic industry, visit:

Psychedelic Spotlight

The three states debating psychedelic liberalization are Maine, Colorado, and Oklahoma.

In Maine, the bill being debated would legalize psilocybin assisted therapy.

In Oklahoma there are two bills that would put money towards researching psychedelic therapy, specifically to help veterans. One of the bills, however, would also decriminalize psilocybin.

In Colorada, there is a bill being debated that would form a committee to explore decriminalization. There are also two ballot measures that if passed would legalize certain psychedelics.

At the same time, the DEA is adding 5 new psychedelics to schedule 1, the most illegal category

And in Canada, the NDP has proposed a bill that would decriminalize all illegal substances.

Links:
Maine Bill

Maine could legalize ‘magic mushroom’ drug to treat depression

Oklahoma

Oklahoma GOP Lawmakers Push for Psychedelic Reform

Colorado

Colorado Lawmakers and Activists Push for Wide-Ranging Psychedelic Reform

DEA Restrictions

DEA Proposes Adding 5 More Psychedelics to Schedule 1 Controlled Substances

Canada NDP Decriminalization bill
https://www.ctvnews.ca/politics/ndp-to-introduce-new-bill-to-decriminalize-drug-use-as-overdose-deaths-soar-1.5763455

#DEA #Psychedelics #Legalization

source

Similar Posts

  • Top 5 PSYCHEDELIC STOCKS to buy in 2021 (MMEDF, NUMI, RVV, FTRP, CMPS🔥)

    We hope that YOU, the psychedelic investor, were able to gain some value from this! 🧠📈 Feel free to drop a comment! 💬 Also, you can support the channel by liking the video and checking out the links below.👇🏼 Appreciate you. 🙏🏼

    There’s a SHROOM BOOM on its way. Psychedelic companies are IPOing left and right and along with them are the top 5 psychedelic stocks to buy in 2020! On this list we got:

    Revive Therapeutics (RVV), Numinus (NUMI), Field Trip (FTRP), Compass Pathways (CMPS), and last but not least…MinDMed (MMEDF).

    Beat by: Prod. Riddiman
    Stream beats on:
    Spotify: https://spoti.fi/2u4ZS7R
    Apple Music: https://apple.co/2GIxb8j
    Music: www.bensound.com
    Instagram: @psychedelicinvestor
    Facebook: @thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

  • 50 of the Greatest Psychedelic Quotes of All Time

    “Psychedelics and plant-based medicines are powerful tools in the process of healing, particularly for the most marginalized folks living under empire, who are underserved, underrepresented and experience the highest rates of violence. Marginalized communities already have limited access to healing spaces, so I think t’s important for folks invested in justice work to center and prioritize what nontraditional forms of healing look like for these communities.”

  • Speculating on The Future of MindMed [Big News for MMED/MMEDF STOCK]

    Hello back Psychedelic Investors! In this video we are going to be entering the Speculation Zone to discuss the implications of several of MindMed’s most recent moves. Aka, we shall be Speculating on The Future of MindMed [Big News for MMED/MMEDF STOCK].

    Timestamps:
    0:00 – Intro
    2:52 – Speculating on LSD Trials
    7:44 – MindMed’s Partnership Meaning
    13:45 – Nasdaq Uplisting

    This is actually the second video being released today. Earlier we posted a video detailing the three most recent press releases distributed by MindMed, where we explained what each move meant. If you haven’t seen that episode yet and want to get a detailed explanation of each Press Release before watching this video speculating on that information, you should probably do that first!

    Well actually, MindMed has since released another press release since the first video was filmed, on the commencement of their LSD Neutraliser phase 1 clinical trial.
    In our Video on MindMed’s Latest News, we discussed:

    1. How MindMed has started a phase 1 clinical trial studying the effects of mixing LSD and MDMA;
    2. We examined MindMed’s changes in Leadership, where JR Rahn became the sole CEO, and a gentleman by the name of Dr. Glick left the board;
    3. We also talked about MindMed’s new partnership with a company called MindShift Compounds AG, which is developing novel compounds owned exclusively by MMED.

    In this video, we discuss/SPECULATE on all of MindMed’s latest changes and how some of them could potentially influence the MMED/MMEDF stock’s uplisting on NASDAQ.

    I hope you guys found some value in this and I’ll keep you posted for more changes!

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!

    Follow us on social media! 🙌
    Instagram: @psychedelicinvestor
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com
    Video by Pressmaster from Pexels

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    #MindMed #MMEDF #MindmedStock

  • This Week in Psychedelic Stocks [UPDATES ON MINDMED (MMED/MMEDF) CMPS, NUMI, FTPRF, ATAI & CYBN]

    In today’s episode of “This Week in Psychedelic Stocks”, we’ll see some News on MindMed (MMED / MMEDF/MMQ), Compass Pathways (CMPS), Atai Life Sciences, Numinus Wellness (NUMI), Cybin (CYBN) & Fieldtrip Health (FTPRF).

    I covered some breaking news on MindMed yesterday in our impromptu episode on the MindMed stock being added to the EFSE so that mindmed news is not in this episode.

    We will cover the latest developments in the field writ large.
    This means we will cover any stories that affect the all the companies in this field, as well as company specific developments.

    Timestamps:
    0:00 – Intro
    0:43 – Australian federal government funds psychedelic research to treat mental illnesses
    2:19 – Rhode Island wants to decriminalize all drugs
    3:54 – New York Bill to decriminalize psilocybin mushrooms
    6:34 – MindMed stock updates ( mmed, mmedf, mmq )
    8:17 – Compass Pathways stock news (cmps)
    8:49 – Atai Life Sciences news
    12:37 – Fieldtrip Health stock news ( ftprf, ftrp)
    15:04 – Numinus Wellness stock news ( NUMI, LKYSF)
    16:16 – Cybin stock news ( cybn, clxpf)
    18:18 General psychedelics discussion

    So this is it for This Week in Psychedelic Stocks fellow psychedelic investors!

    I hope you guys found some value in this and I’ll keep you posted for more changes!

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌
    Instagram: @psychedelicinvestor
    email: thepsychedelicinvestor@gmail.com
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    #MindMed​​ ​#MindmedStock​​ #PsychedelicStocks